2018 Section 5 - Rhinology and Allergic Disorders

RESOLVE 6-month outcomes

Hopp, MD (Primary Investigator), Laura Sarmiento, CCRP, and Denice Dubuclet, DC, of Cedars-Sinai Medical Center, Los Angeles, CA. Finally, we thank Deborah Bur- ton, RN, Sally Glauz, Neda Haque, Amita Patel, Diptikanti Sahoo, Vicki Schreckengost, MSN, and Jennifer Slocum for the professional support they provided to the clinical sites.

Francine Schnabel of ENT and Allergy Associates, Lake Success, NY, Ronald Shealy, MD (Primary Investigator) and Sandra L. Smith, MBA, CCRC, of Piedmont ENT Associates, Winston-Salem, NC; Jeffrey LeBanger, MD (Primary Investigator) and Kelly M. Ritter, LPN, CCRC, of Summit Medical Group, Berkeley Heights, NJ; Martin

References 1. Doellman MS, Dion GR, Weitzel EK, Reyes EG. Im- munotherapy in allergic fungal sinusitis: the contro- versy continues. A recent review of literature. Allergy Rhinol. 2013;4:e32–e35. 2. Fandino M, Maconald K, Lee J, Witterick I. The use of postoperative topical corticosteroids in chronic rhi- nosinusitis with nasal polyps: a systematic review and meta-analysis. Am J Rhinol Allergy . 2013;27:e146– e157. 3. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus Guidelines. Mayo Clin Proc . 2011;86:427– 443. 4. Schlosser R, Soler Z. Evidence-based treatment of chronic rhinosinusitis with nasal polyps. Am J Rhi- nol Allergy . 2013;27:461–466. 5. Soler ZM, Rudmik L, Hwang PH, Mace JC, Schlosser RJ, Smith TL. Patient-centered decision making in the treatment of chronic rhinosinusitis. Laryngoscope . 2013;123:2341–2346. 6. Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol . 2005;116:1275– 1281. 7. Stjarne P, Mosges R, Jorissen M, et al. A randomized controlled trial of mometasone furoate nasal spray for

the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg . 2006;132:179–185. 8. Lipworth BJ, Jackson CM. Safety of inhaled and in- tranasal corticosteroids: lessons for the new millen- nium. Drug Saf . 2000;23:11–33. 9. Forwith KD, Chandra RK, Yun PT, Miller SK, Jampel HD. ADVANCE: a multisite trial of bioab- sorbable steroid-eluting sinus implants. Laryngo- scope . 2011;121:2473–2480. 10. Marple BF, Smith TL, Han JK, et al. AD- VANCE II: a prospective, randomized study assess- ing safety and efficacy of bioabsorbable steroid- releasing sinus implants. Otolaryngol Head Neck Surg . 2012;146:1004–1011. 11. Murr AH, Smith TL, Hwang PH, et al. Safety and ef- ficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol . 2011;1:23–32. 12. Matheny KE, Carter KB Jr, Tseng EY, Fong KJ. Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series. Int Forum Allergy Rhinol . 2014;4:808–815. 13. Lavigne F, Miller SK, Gould AR, Lanier BJ, Romett JL. Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study. Int Forum Allergy Rhinol . 2014;4:381–389.

14. Ow R, Groppo E, Clutter D, Gawlicka AK. Steroid- eluting sinus implant for in-office treatment of recur- rent polyposis: a pharmacokinetic study. Int Forum Allergy Rhinol . 2014;4:816–822. 15. Han JK, Forwith KD, Smith TL, et al. RESOLVE: a randomized, controlled, blinded study of bioab- sorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol . 2014;4:891–870. 16. Fokkens WJ, Lund VJ, Mullol J, et al. European Posi- tion Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl . 2012;(23):3 p preceding table of con- tents, 1–298. 17. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinos- inusitis: developing guidance for clinical trials. J Al- lergy Clin Immunol . 2006;118(5 Suppl):S17–S61. 18. Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg . 2004;130:157– 163. 19. Stjarne P, Olsson P, Alenius M. Use of mometa- sone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg . 2009;135:296–302.

International Forum of Allergy & Rhinology, Vol. 6, No. 6, June 2016

231